ACLY Antikörper (pSer455)
Kurzübersicht für ACLY Antikörper (pSer455) (ABIN7180487)
Target
Alle ACLY Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer455
-
Kreuzreaktivität
- Human, Affe, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from Human ATP-citrate synthase around the phosphorylation site of S455.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:10000,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Andere Bezeichnung
- ACLY
-
Hintergrund
- ACL antibody, Acly antibody, ACLY_HUMAN antibody, ATP citrate (pro-S) lyase antibody, ATP citrate lyase antibody, ATP citrate synthase antibody, ATP-citrate (pro-S-)-lyase antibody, ATP-citrate synthase antibody, ATPcitrate synthase antibody, ATPCL antibody, Citrate cleavage enzyme antibody, CLATP antibody, OTTHUMP00000164773 antibody
-
UniProt
- P53396
-
Pathways
- Warburg Effekt
Target
-